ストックスクリーナーアプリを入手
148.41
0.79%
1.17
アフターアワーズ：
148.41
前日終値:
$147.24
開ける：
$146.2
24時間の取引高:
3.03M
Relative Volume:
1.09
時価総額：
$40.89B
収益：
$21.37B
当期純損益:
$1.41B
株価収益率:
37.63
EPS:
3.9437
ネットキャッシュフロー:
$3.07B
1週間 パフォーマンス:
+1.48%
1か月 パフォーマンス:
-0.74%
6か月 パフォーマンス:
-23.51%
1年 パフォーマンス:
-14.22%
1日の値動き範囲:
$143.96
$148.46
1週間の範囲:
$143.96
$150.74
52週間の値動き範囲:
$141.82
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Compare BDX vs ISRG, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
148.41 | 40.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
423.63 | 148.23B | 10.58B | 3.00B | 2.83B | 8.2437 |
ALC
Alcon Inc
|
65.66 | 32.36B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.81 | 30.31B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
203.42 | 29.90B | 5.54B | 1.52B | 1.74B | 10.37 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 再開されました | Goldman | Neutral |
| 2026-02-10 | 再開されました | Barclays | Overweight |
| 2026-02-03 | 再開されました | Citigroup | Buy |
| 2025-09-25 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-05-02 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-05-05 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-12-12 | アップグレード | Citigroup | Sell → Neutral |
| 2022-07-11 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-06-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 再開されました | Raymond James | Mkt Perform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 再開されました | Goldman | Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-07 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-02-07 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-01-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-05-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 開始されました | Deutsche Bank | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-06-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-04-10 | アップグレード | Citigroup | Neutral → Buy |
| 2018-01-19 | 再開されました | BofA/Merrill | Buy |
| 2018-01-05 | アップグレード | Citigroup | Sell → Neutral |
| 2018-01-05 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2017-12-29 | 繰り返されました | Deutsche Bank | Buy |
すべてを表示
Becton Dickinson Co (BDX) 最新ニュース
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Becton Dickinson EVP Michael Feld sells $11,051 in stock - Investing.com UK
Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating - Moomoo
Microneedle Drug Delivery Systems Market to Hit USD 14.37 Billion by 2035 Driven by Self-Administered Therapies – SNS Insider - GlobeNewswire Inc.
Becton, Dickinson And Company (BDX): Evaluating Growth Potential With A 24% Upside - DirectorsTalk Interviews
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MSN
Elyra Kidney Stone Laser Launch Tests Becton Dickinson Execution Story - simplywall.st
BD Delivers Kidney Stone Care for Urology Teams with the Elyra Thulium Fiber Laser System - Finviz
New BD laser targets smoother, quieter kidney stone care procedures - Stock Titan
Becton Dickinson and Co stock (US0758871091): new €600 million notes and recent loss raise questio - AD HOC NEWS
Becton, Dickinson and Company (BDX) Announces €600 Million Notes Offering - GuruFocus
Becton Dickinson Euro Finance Issues €600 Million 3.855% Notes Due 2033 Guaranteed by BD - Minichart
Becton Dickinson subsidiary issues €600 million in 3.855% notes due 2033 - Investing.com Canada
Becton Dickinson Issues €600 Million 3.855% Notes Due 2033 to Refinance 2026 Debt - TradingView
Deals tracker: Medtronic to acquire SPR Therapeutics for $650M - Modern Healthcare
A Look at Becton Dickinson & Co (BDX) After 3.2% Gain -- GF Value $194.45 vs Price $146.95 - GuruFocus
Nebulizers - GlobeNewswire Inc.
BDX Stock Price, Quote & Chart | BECTON DICKINSON AND CO (NYSE:BDX) - ChartMill
Is Wall Street Bullish or Bearish on Becton, Dickinson and Company Stock? - Barchart.com
BD Names Peter Menziuso to Lead $BD Interventional Business - citybiz
Peter Menziuso Named EVP and President, BD Interventional – Company Announcement - Financial Times
Becton, Dickinson and Company (BDX) Stock Analysis: Unveiling a 27.75% Potential Upside - DirectorsTalk Interviews
Becton Dickinson hikes profit outlook, names CFO - MSN
Becton Dickinson and Co stock (US0758871091): earnings beat and strategic focus keep medtech giant i - AD HOC NEWS
DNB Asset Management AS Has $22.28 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Northwestern Mutual Wealth Management Co. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX) Delivers Solid Q2 Performance, Barclays Lifts Target - Insider Monkey
Becton Dickinson & Co(BDX) Stock Options Chain | Quotes & News - Moomoo
Becton Dickinson's (NYSE:BDX) Strong Earnings Are Of Good Quality - Moomoo
Becton Dickinson and Co stock (US0758871091): Drops 2.4% to $143.97 after earnings - AD HOC NEWS
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Becton, Dickinson and Company (BDX) Announces €600 Million Euro Notes Offering - GuruFocus
Becton Dickinson & Co (BDX) News Flow - Moomoo
Becton Dickinson Announces €600 Million Senior Notes Offering - TipRanks
Becton Dickinson launches €600M euro-note offering to refinance 2026 notes - TradingView
This Becton Dickinson Insider Increased Their Holding In The Last Year - Moomoo
Becton, Dickinson and Company $BDX Shares Bought by First Eagle Investment Management LLC - MarketBeat
Crossmark Global Holdings Inc. Grows Stake in Becton, Dickinson and Company $BDX - MarketBeat
May 11, 2026FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses - Becton Dickinson
Is Becton Dickinson & Co (BDX) a Bargain After 4.2% Drop? GF Val - GuruFocus
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
BD appoints Vitor Roque as permanent CFO - MedTech Dive
Dental Needle Market Is Going to Boom |• BD (Becton Dickinson and Company) • Terumo Corporation - openPR.com
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $204 - Moomoo
Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board” - Insider Monkey
Becton, Dickinson and Company Q2 Earnings Call Highlights - sharewise.com
Becton, Dickinson & Co. Hits Day High with Strong 5.87% Surge - Markets Mojo
4: Statement of changes in beneficial ownership of securities - Becton Dickinson
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says - Moomoo
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $175 - 富途牛牛
Becton Dickinson Co (BDX) 財務データ
収益
当期純利益
現金流量
EPS
1.04%
2.71%
大文字化:
|
ボリューム (24 時間):